Oral Oncology
Volume 37, Issue 4 , Pages 379-385 , June 2001

Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity

  • H Okamura

      Affiliations

    • Department of Histology and Oral Histology, School of Dentistry, The University of Tokushima, 3-18-15,3 Kuramoto, Tokushima 770-8504, Japan
    • ,
  • H Morimoto

      Affiliations

    • Department of Histology and Oral Histology, School of Dentistry, The University of Tokushima, 3-18-15,3 Kuramoto, Tokushima 770-8504, Japan
    • First Department of Oral Anatomy, Kyushu Dental College, Kitakyushu 803-8580, Japan
    • ,
  • T Haneji

      Affiliations

    • Department of Histology and Oral Histology, School of Dentistry, The University of Tokushima, 3-18-15,3 Kuramoto, Tokushima 770-8504, Japan
    • Corresponding Author InformationCorresponding author. Tel.: 81-88-633-7321; fax: 81-88-633-7342

Received 26 July 2000 ,Accepted 7 August 2000.

References 

  1. Tanaka W. Development of new bleomycins with potential clinical utility. Journal of Antibiotics. 1977;30:41–48
  2. Umezawa H, Takita T, Sugiura Y, Otsuka M, Kobayashi S, Ohno M. DNA-bleomycin interaction. Nucleotide sequence-specific binding and cleavage of DNA by bleomycin. Tetrahedron. 1984;40:501–509
  3. Byrnes RW, Petering DH. DNA double-strand breakage by bleomycin in Ehrlich ascites tumour cells as measured by nondenaturing filter elution. Radiation Research. 1994;137:162–170
  4. Hamakawa H, Bao Y, Takarada M, Tanioka H. Histological effects and predictive biomarkers of TPP induction chemotherapy for oral carcinoma. Journal of Oral Pathology and Medicine. 1998;27:87–94
  5. Doi R, Makino T, Adachi H, Ryoke K, Ito H. Pre-operative radio-chemotherapy enhances apoptotic cell death in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 1998;27:382–387
  6. Urade M, Ogura T, Mima T, Matsuya T. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer. 1992;69:2589–2597
  7. Urade M, Ogura T, Uematsu T, Takahashi Y, Kishimoto H, Yoshioka W. Induction of bleomycin resistance in a human oral squamous carcinoma cell line and characterisation of bleomycin-resistant-and-sensitive clones. European Journal of Cancer Part B Oral Oncology. 1994;30:409–414
  8. Ozawa S, Suzuki H, Yamaki H, Nishimura T, Tanaka N. A peplomycin-supersensitive cell line lacking activation of poly (adenosine diphosphate ribose) synthetase by peplomycin. Biochemical and Biophysical Research Communications. 1988;151:1305–1311
  9. Ikeda S, Ozaki K. Action of mitochondrial endonuclease G on DNA damaged by L-ascorbic acid, peplomycin, and cis-diamminedichloroplatinum (II). Biochemical and Biophysical Research Communications. 1997;235:291–294
  10. Kerr JFR, Wyllie AH, Currie AR. Apoptosis (a basic biological phenomenon with wide-ranging implications in tissue kinetics). British Journal of Cancer. 1972;26:239–257
  11. Arends MJ, Wyllie AH. Apoptosis (mechanisms and roles in pathology). International Review of Experimental Pathology. 1991;32:223–254
  12. Fisher DE. Apoptosis in cancer therapy (crossing the threshold). Cell. 1994;78:539–542
  13. Steller H. Mechanisms and genes of cellular suicide. Science. 1995;267:1445–1449
  14. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell. 1997;88:347–354
  15. Nagata S. Apoptotic DNA fragmentation. Experimental Cell Research. 2000;256:12–18
  16. Tounekti O, Pron G, Belehradek J, Mir LM. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Research. 1993;53:5462–5469
  17. Hamilton RF, Li L, Felder TB, Holian A. Bleomycin induces apoptosis in human alveolar macrophages. American Journal of Physiology. 1995;269:L318–L325
  18. Suginaka R, Izui R, Inoue J, Muraoka Y, Yamaguchi K, Otsuka M, et al. Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand. Japanese Journal of Cancer Research. 1988;89:947–953
  19. Vernole P, Tedeschi B, Caporossi D, Maccarrone M, Melino G. Induction of apoptosis by bleomycin in resting and cycling human lymphocytes. Mutagenesis. 1998;13:209–215
  20. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. American Journal of Physiology. 2000;277:L143–L151
  21. Tai KW, Chou MY, Hu CC, Yang JJ, Chang YC. Induction of apoptosis in KB cells by pingyangmycin. European Journal of Cancer Part B Oral Oncology. 2000;36:242–247
  22. Takenouchi T, Munekata E. Trophic effect of substance P and β-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sciences. 1995;56:479–484
  23. Fujita M, Seta C, Fukuda J, Kobayashi S, Haneji T. Induction of apoptosis in human oral squamous carcinoma cell lines by protein phosphatase inhibitors. European Journal of Cancer Part B Oral Oncology. 1999;35:401–408
  24. Reid CJ, van der Sterre ML, Tobi H, Leemans CR, Snow GB, Braakhuis BJ. A comparison of bleomycin-induced damage in lymphocytes and primary oral fibroblasts and keratinocytes in 30 subjects. Mutagenesis. 1999;14:87–93
  25. Taron M, Plasencia C, Abad A, Martin C, Guillot M. Cytotoxic effects of topotecan combined with various active G2/M-phase anticancer drugs in human tumor-derived cell lines. Investigational New Drugs. 2000;18:139–147
  26. Lin PS, Kwock L, Hefter K, Missbeck G. Effects of iron, copper, cobalt and their chelations on the cytotoxicity of bleomycin. Cancer Research. 1983;43:1049–1053
  27. Zhang B, Seki S, Ikeda S. DNA damage by peplomycin and its repair in an in vitro system. International Journal of Biochemistry. 1991;23:703–711
  28. Kerr JFR, Winterford CM, Harmon BV. Apoptosis (its significance in cancer and cancer therapy). Cancer. 1994;73:2013–2026
  29. Bamford M, Walkinshaw G, Brown R. Therapeutic applications of apoptosis research. Experimental Cell Research. 2000;256:1–11
  30. Kaufmann SH, Earnshaw X. Induction of apoptosis by cancer chemotherapy. Experimental Cell Research. 2000;56:42–49
  31. Muraki Y, Yoshioka C, Tateishi A, Fukuda J, Haneji T, Kobayashi N. Localization of Fas antigen in oral squamous cell carcinoma. British Journal of Oral & Maxillofacial Surgery. 1999;37:37–40
  32. Seta C, Fujita M, Muraki Y, Fukuda J, Kobayashi S, Haneji T. Fas expression and Fas monoclonal antibody-induced apoptosis in human squamous cell carcinoma cell line, SCC-25. Journal of Oral Pathology and Medicine. 2000;29:271–278
  33. Muraki Y, Yoshioka-Seta C, Tateishi A, Fukuda J, Haneji T, Kobayashi N. Fas expression and prognosis of oral squamous cell carcinoma. International Journal of Oral and Maxillofacial Surgery 2000 (in press).

PII: S1368-8375(00)00101-9

Oral Oncology
Volume 37, Issue 4 , Pages 379-385 , June 2001

Article Tools

* Image Usage & Resolution